Primary outcome measure Using latent class analysis and agglomerative hierarchical clustering algorithms, we analysed the clustering of cardiometabolic diseases (CMDs) including high blood sugar, ...

New research reveals how simple lifestyle changes can mitigate the dual threat of cardiometabolic diseases and air pollution on cognitive health. Study: Association between air pollution and ...

Amblyopia may serve as a neurodevelopmental model for researching early life health factors and disease. First author Siegfried Karl Wagner, MD, FRCOphth, and colleagues, who conducted a study to ...

Notably, seven of the first 10 drugs selected for negotiation are for cardiometabolic disease.” Essa and colleagues used publicly available Medicare part D claims data from 2012 to 2021 to ...

The differential impact of serum lipids and their targets for lipid modification on cardiometabolic disease risk is debated. This study used Mendelian randomization to investigate the causal ...

This Research Topic aims to explore the use of RNA molecules in the diagnosis and treatment of cardiometabolic diseases, highlighting their potential as both diagnostics and therapeutics. It will ...

Nat Clin Pract Cardiovasc Med. 2006;3(3):116-117. P.E. Szmitko is a Resident in the Division of General Internal Medicine, and S Verma is a Scientist and Assistant Professor in the Division of ...

Cardiovascular disease is a major contributor to maternal mortality in the U.S. Cardiometabolic comorbidities such as diabetes, hypertension, obesity, and hyperlipidemia are associated with both short ...

FEV1/FVC unrelated to other diseases: There were no significant associations between FEV1/FVC and the occurrence of heart disease or stroke. Low FVC emerged as a critical determinant of ...

Both serum testosterone (T) levels and erectile dysfunction (ED) are associated with systemic diseases in men and ED is the most common presenting symptom of hypogonadism. To evaluate the association ...

Updates in new antiplatelet therapies, new patient populations for PCI and AI to guide CAD staging were among the top developments in thrombosis and coronary disease from 2024.